等待开盘 11-02 09:30:00 美东时间
-0.660
-8.62%
Sigma Lithium Corporation (NASDAQ:SGML) resumed its mining-industrial operations after Senior Federal Judge Mônica Sifuentes of Brazil’s Federal Court of Appeals granted an emergency motion reinstating the company’s environmental licenses. The landmark decision overturned a local federal court rulin...
10-07 22:41
Sigma Lithium (SGML) jumped 6.3% pre-market Wednesday after saying it will resume mining and processing operations at its Grota do Cirilo project in Brazil after a federal appeals court upheld its env...
10-07 19:23
今日重点评级关注:Ascendiant Capital:维持NRX Pharmaceuticals"买入"评级,目标价从49美元升至50美元;Ascendiant Capital:维持Atossa Therapeutics"买入"评级,目标价从24美元升至25美元
10-02 08:33
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. BTIG analyst Julian Harrison downgraded Liquidia Corporation (NASDAQ:LQDA) from Buy to Neutral. L...
10-01 23:56
Sigma Lithium ( ($TSE:SGML) ) has provided an announcement. On September 28, 20...
09-28 20:49
今日重点评级关注:康托·菲茨杰拉德:维持Abeona Therapeutics"超配"评级,目标价从28美元升至30美元;HC Wainwright & Co.:维持Oculis Holding"买入"评级,目标价从26美元升至39美元
09-21 16:25
JP Morgan analyst Lucas Ferreira initiates coverage on Sigma Lithium (NASDAQ:SGML) with a Overweight rating and announces Price Target of $14.
09-18 23:35
On Friday, Sigma Lithium (NASDAQ:SGML) discussed second-quarter financial results during its earnings call. The full transcript is provided below. Benzinga APIs provide real-time access to earnings call transcripts and financial data. Visit https://www.benzinga.com/apis/ to learn more. View the webc...
09-18 19:29
Sigma Lithium (SGML) sinks 13.3% in Tuesday's trading after a Brazilian court ordered the suspension of all environmental permits for the company's Sigma Mineração subsidiary and the complete halt of ...
09-08 23:47
U.S. stock futures were lower this morning, with the Dow futures falling over 400 points on Tuesday. Shares of Novartis AG (NYSE:NVS) fell sharply in pre-market trading after the company disclosed that the pelacarsen phase III Lp(a) HORIZON trial did not meet its primary endpoint. Novartis shares tu...
09-08 20:01